Vijaya Diagnostic Centre has received the final order from the National Company Law Tribunal (NCLT), Hyderabad, approving the Scheme of Amalgamation with Medinova Diagnostic Services Limited. The effective date will be communicated once the certified true copy of the order is filed with the Registrar of Companies. This merger aims to consolidate the businesses and create synergies between Vijaya and Medinova.
Amalgamation Scheme Approved
Vijaya Diagnostic Centre Limited announced that the National Company Law Tribunal (NCLT), Hyderabad, has approved the Scheme of Amalgamation between Medinova Diagnostic Services Limited and Vijaya Diagnostic Centre Limited, a move aimed at streamlining operations and enhancing shareholder value. The order was officially received on October 13, 2025.
Details of the Amalgamation
The company is now proceeding with filing the certified true copy of the NCLT order with the jurisdictional Registrar of Companies, Hyderabad. The Effective Date of the Scheme will be the date of filing with the Registrar. This date will be formally communicated to the stock exchanges for public dissemination. The company will also announce the record date for determining the eligible public shareholders of Medinova entitled to receive shares of Vijaya Diagnostic Centre Limited.
Rationale Behind the Amalgamation
Vijaya Diagnostic Centre views this amalgamation as a strategic step to consolidate the businesses and create synergies between the two entities. The aim is to achieve greater efficiency in cash management, pool resources, and accelerate growth. The company believes the amalgamation will lead to revenue synergies, more focused operational efforts, and simplification of business processes.
Key Observations from NCLT Order
The National Company Law Tribunal (NCLT) order outlines several key points and directives concerning this amalgamation:
The NCLT Order No. 23/230/HDB/2025 connected with CA(CAA) No.10/230/HDB/2025 details orders, pronouncements, and records, allowing the Company Petition. Further, clarifies compliance with accounting standards, accounting treatment proposed at Clause 24 and Clause 25 of Section 1 of Part C of the Scheme, in conformity with accounting standards as prescribed under the provisions of Section 133 of the Companies Act, 2013.
Source: BSE
